{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:57:53Z","timestamp":1790423873875,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00774-017-0817-8","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T07:28:08Z","timestamp":1488180488000},"page":"128-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Nicola","family":"Veronese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sergi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Manzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"817_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kr\u00f6ger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M, International Myeloma Working Group (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121\u20131127. doi:\n                        10.1038\/leu.2010.60","journal-title":"Leukemia"},{"key":"817_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. New Eng J Med 354:1362\u20131369. doi:\n                        10.1056\/NEJMoa054494","journal-title":"New Eng J Med"},{"key":"817_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/jbmr.2387","volume":"29","author":"MT Drake","year":"2014","unstructured":"Drake MT (2014) unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res Off J Am Soc Bone Miner Res 29:2529\u20132533. doi:\n                        10.1002\/jbmr.2387","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"817_CR4","first-page":"28","volume":"23","author":"MT Drake","year":"2009","unstructured":"Drake MT (2009) Bone disease in multiple myeloma. Oncology (Williston Park, NY) 23:28\u201332","journal-title":"Oncology (Williston Park, NY)"},{"key":"817_CR5","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. doi:\n                        10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"key":"817_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08761-5","author":"WH Organization","year":"2004","unstructured":"Organization WH (2004) Who scientific group on the assessment of osteoporosis at primary health care level. World Health Org. doi:\n                        10.1016\/S0140-6736(02)08761-5","journal-title":"World Health Org"},{"key":"817_CR7","doi-asserted-by":"publisher","unstructured":"Wells G, Shea BJ, O'Connell D, je Peterson, Welch V, Losos M, Tugwell P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. (\n                        http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp)\n                        \n                     2012. doi:\n                        10.2307\/632432\n                        \n                    . Accessed 20 July 2016","DOI":"10.2307\/632432"},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188. doi:\n                        10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"817_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. doi:\n                        10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"817_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00277-007-0376-5","volume":"87","author":"O Dizdar","year":"2008","unstructured":"Dizdar O, Erman M, Cankurtaran M, Halil M, Ulger Z, Yavuz BB, Ariogul S, P\u0131nar A, Harputluoglu H, Kars A, \u00c7elik \u0130 (2008) Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance. Ann Hematol 87:57\u201360. doi:\n                        10.1007\/s00277-007-0376-5","journal-title":"Ann Hematol"},{"key":"817_CR11","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","volume":"118","author":"AC Ng","year":"2011","unstructured":"Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF, McCready LK, Melton LJ 3rd, Kyle RA, Rajkumar SV, Drake MT (2011) Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1\u03b1 levels in patients with MGUS. Blood 118:6529\u20136534. doi:\n                        10.1182\/blood-2011-04-351437","journal-title":"Blood"},{"key":"817_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","volume":"134","author":"J Pepe","year":"2006","unstructured":"Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E, Minisola S (2006) Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 134:485\u2013490. doi:\n                        10.1111\/j.1365-2141.2006.06217.x","journal-title":"Br J Haematol"},{"key":"817_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/bmj.38376.401701.8F","volume":"330","author":"B Abrahamsen","year":"2005","unstructured":"Abrahamsen B, Andersen I, Christensen SS, Madsen JS, Brixen K (2005) Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study. BMJ 330:818. doi:\n                        10.1136\/bmj.38376.401701.8F\n                        \n                     (clinical research ed)","journal-title":"BMJ"},{"key":"817_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000162282","volume":"120","author":"T Golombick","year":"2008","unstructured":"Golombick T, Diamond T (2008) Prevalence of monoclonal gammopathy of undetermined significance\/myeloma in patients with acute osteoporotic vertebral fractures. Acta Haematol 120:87\u201390. doi:\n                        10.1159\/000162282","journal-title":"Acta Haematol"},{"key":"817_CR15","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1038\/bcj.2015.71","volume":"5","author":"JM Piot","year":"2015","unstructured":"Piot JM, Royer M, Schmidt-Tanguy A, Hopp\u00e9 E, Gardembas M, Bourr\u00e9e T, Hunault M, Fran\u00e7ois S, Boyer F, Ifrah N, Renier G, Chevailler A, Audran M, Chappard D, Libouban H, Mabilleau G, Legrand E, Bouvard B (2015) Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance. Blood Cancer J 5:e345. doi:\n                        10.1038\/bcj.2015.71","journal-title":"Blood Cancer J"},{"key":"817_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0025-6196(11)60518-1","volume":"84","author":"JP Bida","year":"2009","unstructured":"Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd, Plevak MF, Larson DR, Dispenzieri A, Katzmann JA, Rajkumar SV (2009) Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 84:685\u2013693. doi:\n                        10.1016\/S0025-6196(11)60518-1","journal-title":"Mayo Clin Proc"},{"key":"817_CR17","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","volume":"116","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Tang M, Pfeiffer RM, Bj\u00f6rkholm M, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010) Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood 116:2651\u20132655. doi:\n                        10.1182\/blood-2010-04-282848","journal-title":"Blood"},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","volume":"135","author":"H Gregersen","year":"2006","unstructured":"Gregersen H, Jensen P, Gislum M, J\u00f8rgensen B, S\u00f8rensen HT, N\u00f8rgaard M (2006) Fracture risk in patients with monoclonal gammopathy of undetermined significance. Br J Haematol 135:62\u201367. doi:\n                        10.1111\/j.1365-2141.2006.06269.x","journal-title":"Br J Haematol"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-016-0258-3","volume":"11","author":"F Malgo","year":"2016","unstructured":"Malgo F, Appelman-Dijkstra NM, Termaat MF, van der Heide HJL, Schipper IB, Rabelink TJ, Hamdy NAT (2016) High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD. Arch Osteoporos 11:1\u20138. doi:\n                        10.1007\/s11657-016-0258-3","journal-title":"Arch Osteoporos"},{"key":"817_CR20","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD (2006) Bone quality\u2013the material and structural basis of bone strength and fragility. New Eng J Med 354:2250\u20132261. doi:\n                        10.1056\/NEJMra053077","journal-title":"New Eng J Med"},{"key":"817_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldu016","volume":"111","author":"RE Walker","year":"2014","unstructured":"Walker RE, Lawson MA, Buckle CH, Snowden JA, Chantry AD (2014) Myeloma bone disease: pathogenesis, current treatments and future targets. Br Med Bull 111:117\u2013138. doi:\n                        10.1093\/bmb\/ldu016","journal-title":"Br Med Bull"},{"key":"817_CR22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1213\/ANE.0000000000001596","volume":"123","author":"JE Dalton","year":"2016","unstructured":"Dalton JE, Bolen SD, Mascha EJ (2016) Publication bias: the elephant in the review. Anesth Analg 123:812\u20133","journal-title":"Anesth Analg"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-017-0817-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-017-0817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-017-0817-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T16:05:51Z","timestamp":1513785951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-017-0817-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1007\/s00774-017-0817-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}